These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 5456856)

  • 21. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV; Vasil'eva IA; Chernousova LN
    Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistant mycobacterium tuberculosis: report of a family in Connecticut.
    Gerstenhaber BJ
    Conn Med; 1980 Jul; 44(7):416-8. PubMed ID: 6772373
    [No Abstract]   [Full Text] [Related]  

  • 23. Rifampicin--a leading drug in the therapy of tuberculosis not easily amenable to treatment.
    Tousek J
    Respiration; 1971; 28():Suppl:116-22. PubMed ID: 5150791
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifampicin in the treatment of chronic pulmonary tuberculosis. Investigations on clinical activity and side effects.
    Pickroth G; Anschel R; Kalich R; Kandt D
    Acta Tuberc Pneumol Belg; 1969; 60(3):513-8. PubMed ID: 5371676
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin].
    Baba H
    Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic effect of Rifampicin on re-treatment cases of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):227-35. PubMed ID: 5449510
    [No Abstract]   [Full Text] [Related]  

  • 28. [The present situation, treatment and prognosis of drug-resistant pulmonary tuberculosis. Cooperative Study Unit of Chemotherapy of Tuberculosis of the National Sanitoria in Japan].
    Sato K; Nagai H; Kurashima A; Mori M; Katayama T
    Kekkaku; 1995 Oct; 70(10):585-9. PubMed ID: 8523851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The clinical significance of the critical drug concentration of rifampicin. Report 2. Clinical investigation: the emergence and reversion of resistance (author's transl)].
    Baba H; Azuma Y
    Kekkaku; 1976 Jan; 51(1):7-12. PubMed ID: 815710
    [No Abstract]   [Full Text] [Related]  

  • 30. Pre- and postoperative treatment of chronic multiresistant cases of pulmonary tuberculosis with rifampicin.
    Rzepecki WM; Lodziak A
    Chemotherapy; 1974; 20(2):12-4. PubMed ID: 4367637
    [No Abstract]   [Full Text] [Related]  

  • 31. [Rifampicin in chronic pulmonary tuberculosis].
    Levit T; Terracina S; Karman S
    Harefuah; 1971 Jun; 80(11):604-6. PubMed ID: 5157984
    [No Abstract]   [Full Text] [Related]  

  • 32. [3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].
    Hennebert A
    Acta Tuberc Pneumol Belg; 1969; 60(3):507-12. PubMed ID: 5371675
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of initial treatment of pulmonary tuberculosis using ethambutol, isonicotinic acid hydrazide and rifampicin].
    Kesztele V; Niederkofler J
    Wien Med Wochenschr; 1970 Jun; 120(25):473-5. PubMed ID: 5518004
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug sensitivity in Mycobacterium tuberculosis versus its viability, cytotoxicity, genotype, and the course of the process in patients with pulmonary tuberculosis].
    Manicheva OA; Lasunskaia EB; Zhuravlev VIu; Otten TF; Barnaulov AO; Mokrousov IV; Pavlova MV; Vishnevskiĭ BI; Narvskaia OV
    Probl Tuberk Bolezn Legk; 2008; (12):18-22. PubMed ID: 19230183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Place of ethambutol associated with isoniazid or with rifampicin in the treatment of pulmonary tuberculosis].
    Lesobre R; Frey N
    Therapeutique; 1971 Apr; 47(4):387-90. PubMed ID: 5564051
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.